Lilly's Alzheimer's results cap 25-year scientific quest; FDA approves first RSV vaccine

Taking stock of the drug industry, from the lab to the medicine chest

May 3, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Sarah Gonzalez for STAT Sarah Gonzalez for STAT For Eli Lilly's head scientist, Alzheimer's results cap a 25-year scientific quest Daniel Skovronsky, Eli Lilly's chief scientific officer, has been "pursuing the same enemy" for much of his career. By Damian Garde FDA approves first RSV vaccine, a long-sought scientific achievement A vaccine that was developed by Pfizer and aimed at the same demographic as GSK's Arexvy is expected to be approved by the end of the month. By Helen Branswell DEA will delay telemedicine restrictions for buprenorphine, Adderall, and other drugs The proposal, which drew criticism, would have tightened access to drugs like buprenorphine for opioid addiction and Adderall for ADHD. By Lev Facher Adobe Oft-prescribed beta blockers may not be wise for many heart patients Two new studies suggest that it's time to question the common, long-term use of beta blockers for heart attack or heart failure patients. By Elaine Chen Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity After a decade as a symbol for the power of innovative medicines, childhood cancer survivor Emily Whitehead is ready for what's next. By Jason Mast STAT+ | In early glimpse at data, Akili's video game shows positive results with adults with ADHD Akili Interactive revealed top-line clinical trial results suggesting its video game treatment for ADHD is effective for adults. By Mario Aguilar Virginia Commonwealth University Libraries STAT+ | Immunogen ovarian cancer drug shown to extend patients' lives The company said the data make Elahere the first drug to show a survival benefit in patients who progress after platinum chemotherapy. By Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser